Meno a priezvisko:
|
MUDr. Erik Kozubík, PhD.
|
Typ dokumentu:
|
Vedecko/umelecko-pedagogická charakteristika osoby
|
Názov vysokej školy:
|
Univerzita Komenského v Bratislave
|
Sídlo vysokej školy:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Zamestnanie-pracovné zaradenie | III.b - Inštitúcia | III.c - Časové vymedzenie |
---|---|---|
Odborný asistent | Jesseniova lekárska fakulta, Univerzita Komenského | od 2022 |
V.1.a - Názov profilového predmetu | V.1.b - Študijný program | V.1.c - Stupeň | V.1.d - Študijný odbor |
---|---|---|---|
Gynekológia a pôrodníctvo 1, 2 a 3 | Všeobecné lekárstvo | I.+II. | Všeobecné lekárstvo |
Letná prax v gynekológii a pôrodníctve | Všeobecné lekárstvo | I.+II. | Všeobecné lekárstvo |
Gynekológia 1 a 2 | Pôrodná asistencia | I. | Pôrodná asistencia |
Pôrodníctvo 1, 2 a 3 | Pôrodná asistencia | I. | Pôrodná asistencia |
Gynekológia a pôrodníctvo | Zubné lekárstvo | I.+II. | Zubné lekárstvo |
ADC01 Kúdela, Erik [KAUT] [UKOLJ150] (40%) - Samec, Marek [UKOLJ120] (15%) - Koklesová, Lenka
[UKOLJ120] (15%) - Mazuráková, Alena [UKOLJ120] (15%) - Kubatka, Peter [UKOLJ120] (4%) - Kozubík,
Erik [UKOLJ150] (1%) - Rokos, Tomáš [UKOLJ150] (1%) - Pribulová, Terézia [UKOLJ150] (1%) - Kúdelová,
Eva [UKOLJ300 01.2022] (3%) - Smolár, Marek [UKOLJ300 01.2022] (4%) - Biringer, Kamil [UKOLJ150]
(1%): miRNA expression profiles in luminal a breast cancer implications in biology, prognosis, and prediction of
response to hormonal treatment [elektronický dokument] (Citations 17)
ADC02 Kúdela, Erik [UKOLJ150] (40%) - Mazuráková, Alena [UKOLJ120] (15%) - Samec, Marek [UKOLJ120]
(19%) - Koklesová, Lenka [UKOLJ120] (5%) - Holubeková, Veronika [UKOLJ110] (5%) - Rokos, Tomáš
[UKOLJ150] (2%) - Kozubík, Erik [UKOLJ150] (2%) - Pribulová,Terézia [UKOLJ150] (2%) - Zhai, Kevin (1%)
- Büsselberg, Dietrich (2%) - Kubatka, Peter [UKOLJ120] (5%) - Biringer, Kamil [KAUT] [UKOLJ150] (2%):
The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and
personalized medical approach to combat HPV-induced cervical cancer (Citations 7)
ADM01 Biringer, Kamil [UKOLJ150] (75%) - Siváková, Jana (2%) - Marcinek, Juraj [UKOLJ] (10%) - Pribulová, Terézia [UKOLJ150] (2%) - Rokos, Tomáš [UKOLJ150] (2%) - Kozubík, Erik [UKOLJ150] (2%) - Kúdela, Erik
[KAUT] [UKOLJ150] (5%) - Plank, Lukáš[UKOLJ251] (2%): Placental pathology concerning sudden foetal
demise in sars-cov-2 positive asymptomatic pregnant female [elektronický dokument] (Citations 4)
V301 Holubeková, Veronika [UKOLJ110] (16%) - Kolková, Zuzana [UKOLJ110] (8%) - Kašubová, Ivana
[UKOLJ110] (8%) - Samec, Marek [UKOLJ261] (8%) - Mazuráková, Alena [UKOLJ120] (8%) - Koklesová,
Lenka [UKOLJ120] (8%) - Kubatka, Peter [UKOLJ120] (8%) - Rokos,Tomáš [UKOLJ150] (8%) - Kozubík, Erik
[UKOLJ150] (8%) - Biringer, Kamil [UKOLJ150] (8%) - Kúdela, Erik [KAUT] [UKOLJ150] (12%): Interaction
of cervical microbiome with epigenome of epithelial cells: Significance of inflammation to primary
healthcare (Citations 3)
V301 Rokos, Tomáš [UKOLJ150, 25%] ; Holubeková, Veronika [UKOLJ110, 25%] ; Kolková, Zuzana [UKOLJ110, 3.75%] ; Hornáková, Andrea [UKOLJ110, 3.75%] ; Pribulová, Terézia [UKOLJ150, 3.75%] ; Kozubík, Erik [UKOLJ150, 3.75%] ; Biringer, Kamil [UKOLJ150, 10%] ; Kúdela, Erik [UKOLJ150, 25%]: Is the Physiological Composition of the Vaginal Microbiome Altered in High-Risk HPV Infection of the Uterine Cervix? (Citations 2)
ADC01 Kúdela, Erik [KAUT] [UKOLJ150] (40%) - Samec, Marek [UKOLJ120] (15%) - Koklesová, Lenka
[UKOLJ120] (15%) - Mazuráková, Alena [UKOLJ120] (15%) - Kubatka, Peter [UKOLJ120] (4%) - Kozubík,
Erik [UKOLJ150] (1%) - Rokos, Tomáš [UKOLJ150] (1%) - Pribulová, Terézia [UKOLJ150] (1%) - Kúdelová,
Eva [UKOLJ300 01.2022] (3%) - Smolár, Marek [UKOLJ300 01.2022] (4%) - Biringer, Kamil [UKOLJ150]
(1%): miRNA expression profiles in luminal a breast cancer implications in biology, prognosis, and prediction of
response to hormonal treatment [elektronický dokument] (Citations 17)
ADC02 Kúdela, Erik [UKOLJ150] (40%) - Mazuráková, Alena [UKOLJ120] (15%) - Samec, Marek [UKOLJ120]
(19%) - Koklesová, Lenka [UKOLJ120] (5%) - Holubeková, Veronika [UKOLJ110] (5%) - Rokos, Tomáš
[UKOLJ150] (2%) - Kozubík, Erik [UKOLJ150] (2%) - Pribulová,Terézia [UKOLJ150] (2%) - Zhai, Kevin (1%)
- Büsselberg, Dietrich (2%) - Kubatka, Peter [UKOLJ120] (5%) - Biringer, Kamil [KAUT] [UKOLJ150] (2%):
The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and
personalized medical approach to combat HPV-induced cervical cancer (Citations 7)
ADM01 Biringer, Kamil [UKOLJ150] (75%) - Siváková, Jana (2%) - Marcinek, Juraj [UKOLJ] (10%) - Pribulová, Terézia [UKOLJ150] (2%) - Rokos, Tomáš [UKOLJ150] (2%) - Kozubík, Erik [UKOLJ150] (2%) - Kúdela, Erik
[KAUT] [UKOLJ150] (5%) - Plank, Lukáš[UKOLJ251] (2%): Placental pathology concerning sudden foetal
demise in sars-cov-2 positive asymptomatic pregnant female [elektronický dokument] (Citations 4)
V301 Holubeková, Veronika [UKOLJ110] (16%) - Kolková, Zuzana [UKOLJ110] (8%) - Kašubová, Ivana
[UKOLJ110] (8%) - Samec, Marek [UKOLJ261] (8%) - Mazuráková, Alena [UKOLJ120] (8%) - Koklesová,
Lenka [UKOLJ120] (8%) - Kubatka, Peter [UKOLJ120] (8%) - Rokos,Tomáš [UKOLJ150] (8%) - Kozubík, Erik
[UKOLJ150] (8%) - Biringer, Kamil [UKOLJ150] (8%) - Kúdela, Erik [KAUT] [UKOLJ150] (12%): Interaction
of cervical microbiome with epigenome of epithelial cells: Significance of inflammation to primary
healthcare (Citations 3)
V301 Rokos, Tomáš [UKOLJ150, 25%] ; Holubeková, Veronika [UKOLJ110, 25%] ; Kolková, Zuzana [UKOLJ110, 3.75%] ; Hornáková, Andrea [UKOLJ110, 3.75%] ; Pribulová, Terézia [UKOLJ150, 3.75%] ; Kozubík, Erik [UKOLJ150, 3.75%] ; Biringer, Kamil [UKOLJ150, 10%] ; Kúdela, Erik [UKOLJ150, 25%]: Is the Physiological Composition of the Vaginal Microbiome Altered in High-Risk HPV Infection of the Uterine Cervix? (Citations 2)
[o1] 2022 Schwartz DA, Avvad-Portari E, Babál P, Baldewijns M, Blomberg M, Bouachba A, Camacho J, Collardeau-Frachon S, Colson A, Dehaene I, Ferreres JC, Fitzgerald B, Garrido-Pontnou M, Gergis H, Hargitai B, Helguera-Repetto AC, Holmström S, Irles CL, Leijonhfvud Å, Libbrecht S, Marton T, McEntagart N, Molina JT, Morotti R, Nadal A, Navarro A, Nelander M, Oviedo A, Otani ARO, Papadogiannakis N, Petersen AC, Roberts DJ, Saad AG, Sand A, Schoenmakers S, Sehn JK, Simpson PR, Thomas K, Valdespino-Vázquez MY, van der Meeren LE, Van Dorpe J, Verdijk RM, Watkins JC, Zaigham M. Placental Tissue Destruction and Insufficiency From COVID-19 Causes Stillbirth and Neonatal Death From Hypoxic-Ischemic Injury. SCOPUS
[o1] 2007 Liskova A, Samec M, Koklesova L, Kudela E, Kubatka P, Golubnitschaja O. Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine. Int J Mol Sci. 2021 Feb 18;22(4), SCOPUS
[o1] 2021 Favero A, Segatto I, Perin T, Belletti B. The many facets of miR-223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response. Wiley Interdiscip Rev RNA. SCOPUS
[o1] 2022 Schwartz DA. Stillbirth after COVID-19 in Unvaccinated Mothers Can Result from SARS-CoV-2 Placentitis, Placental Insufficiency, and Hypoxic Ischemic Fetal Demise, Not Direct Fetal Infection: Potential Role of Maternal Vaccination in Pregnancy. Viruses. ; SCOPUS
[o1] 2021 Amiruddin A, Massi MN, Islam AA, Patellongi I, Pratama MY, Sutandyo N, Natzir R, Hatta M, Md Latar NH, Wahid S. microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study. Ann Med Surg (Lond).; SCOPUS
Lisper. ITMS 313011V446: Integratívna stratégia v rozvoji personalizovanej medicíny vybraných zhubných nádorových ochorení a jej vplyv na kvalitu života. Operačný program Integrovaná infraštruktúra 2014-2023.
VEGA 1/0398/21 „Imunitný systém a vaginálny mikrobióm ako dôležité mediátory v procesecervikálnej karcinogenézy.“